Our Neuromuscular Disease Unit publishes in JAMA Neurology

Dr. Cortés, researcher in the Neuromuscular Disease Unit, Neurology Service, Hospital de la Santa Creu i Sant Pau, is the first author of the article “Clinical characteristics of double-seronegative Patients with Myasthenia Gravis and antibodies to Cortactin”, published in JAMA Neurology. This article focuses on Cortactin identifications, a new antigen in seronegative myasthenia gravis. The presence of the antibodies anti-Cortactin is a biomarker in seronegative myasthenia and suggest the disease will be eye-restricted or mild generalized. These antibodies are a new diagnostic tool useful in the diagnosis and clinical management of these patients.

This website uses cookies to improve the browsing experience and perform analytical tasks. If you continue browsing, we understand that you agree our cookies policy. More information